Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT06790355
NA

ProSight: A Multi-centre Interventional Study Evaluating MCED in Asymptomatic Population

Sponsor: Shanghai Weihe Medical Laboratory Co., Ltd.

View on ClinicalTrials.gov

Summary

This is a prospective, multi-centre interventional study evaluating the feasibility of blood-based multi-cancer early detection test in asymptomatic screening cohort.

Official title: Feasibility of Blood-based Test for Multi-cancer Early Detection in Asymptomatic Screening Population(ProSight): a Multi-centre Interventional Study

Key Details

Gender

All

Age Range

40 Years - 74 Years

Study Type

INTERVENTIONAL

Enrollment

2527

Start Date

2025-03-01

Completion Date

2026-08-31

Last Updated

2026-09-04

Healthy Volunteers

Yes

Interventions

DEVICE

multi-cancer early detection

Blood collection for multi-cancer early detection(MCED), followed by clinical diagnosis based on the results of MCED and standard-of-care screening

Locations (4)

Fujian Cancer Hospital

Fuzhou, Fujian, China

Henan Cancer Hospital

Zhengzhou, Henan, China

Jiangsu Cancer Hospital

Nanjing, Jiangsu, China

Fudan University Shanghai Cancer Center

Shanghai, Shanghai Municipality, China